BTMD

BTMD

biote Corp

biote Corp trains healthcare providers in hormone optimization through bioidentical hormone replacement pellet therapy, offering education, software for inventory and practice management, and dietary supplements. Its services are primarily out-of-pocket for patients.

⚕️ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago $146today

Score Overview

1 Year
Score
Net Growth-78.35%
Net TrendShrank
Net Income Consistency
Rev Growth-4.52%
Rev TrendShrank
Revenue Consistency
5 Years
Score4.0
Net Growth-82.05%
Net Trend40%
Net Income Consistency
Rev Growth31.66%
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth-82.05%
Net Trend40%
Net Income Consistency
Rev Growth31.66%
Rev Trend60%
Revenue Consistency

See the full market ranking →

biote Corp fundamental performance

Between 2021 and 2025, revenue grew from $ 139M to $ 192M and net income declined from $ 32M to $ 27M. Revenue increased in 60% of the years measured; net income in 40%.

biote Corp currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.42
1 Year2025-08-12
$ 2.89-50.87%
5 Years2021-08-12
$ 9.72-85.39%
All Time2021-04-28
$ 10.05-85.87%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 183M$ 5M$ 11M
2025$ 192M$ 27M$ 24M
2024$ 197M$ 3M$ 39M
2023$ 185M$ 3M$ 89M
2022$ 164M-$ 969K$ 79M
IPO2021$ 139M$ 32M$ 26M

Explore beyond BTMD

You're looking at biote Corp. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies